DREAM3R
07 Dec 2020
DREAM3R
NCT04334759
DuRvalumab with chEmotherapy vs chemotherapy alone as first line treAtment in advanced, pleural Mesothelioma – a phase 3 Randomised trial
PrECOG, LLC.
Cancer Type | Lung & mesothelioma |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | - |
Cancer Stage | Locally Recurrent or Locally Advanced |
Anticipated Start Date | 2020-09-01 |
Anticipated End Date | 2025-05-01 |
Hospital | The Queen Elizabeth Hospital |
---|---|
Clinical Trial Coordinator | Pamela Cooper |
pamela.cooper@sa.gov.au | |
Phone | 08 8222 6140 |
Principal Investigator | Dr Rachel Roberts-Thomson |
Recruitment Status | Not Yet Recruiting |